Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $5.70B.
ENTERPRISE VALUE (EV)
$5.70B
GRAIL Inc.
Market Cap
$5.89B
Enterprise Value (EV)
$5.70B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| GRAIL Inc. (GRAL) | $5.89B | $5.70B |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.87B | $5.71B |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | $6.08B |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | $5.72B |
| Kodiak Sciences Inc. (KOD)vs › | $5.78B | $5.75B |
| CG Oncology Inc. (CGON)vs › | $5.61B | $5.60B |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.23B | $6.16B |
| RadNet, Inc. (RDNT)vs › | $5.53B | $6.98B |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | $5.37B |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | $4.96B |
Market Cap
$5.89B
Total Debt
$54.86M
Cash
$249.73M
Enterprise Value
$5.70B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
